TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Leishmaniasis
Studies from N.E. Matta and colleagues yield new information about leishmaniasis
April 21st, 2009
"Cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis (CL-Lguy) is endemic in the Brazilian Amazon, differing from L. braziliensis infection in clinical, diagnostic, and therapeutic aspects. T-cell reactivity to leishmanial antigens possibly involved in the pathogenesis of CL-Lguy was studied herein," scientists writing in the American Journal of Tropical Medicine and Hygiene report. "Variable lymphoproliferative responses (LPRs) to Leishmania antigens were found among the 3 studied patients, and 50% of them showed low or no response to these antigens. Active disease was associated with an enrichment of leishmanial-reactive T lymphocytes, mainly...
Source: TB & Outbreaks Week (2009-04-21)
|
